273
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The safety and efficacy of peroral endoscopic cardial constriction in gastroesophageal reflux disease

, , , , , , , & ORCID Icon show all
Pages 878-883 | Received 01 Jan 2022, Accepted 01 Feb 2022, Published online: 23 Feb 2022

References

  • El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–880.
  • Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17(1):14–27.
  • Francis DO, Rymer JA, Slaughter JC, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108(6):905–911.
  • Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):302–318.
  • Delshad SD, Almario CV, Chey WD, et al. Prevalence of gastroesophageal reflux disease and proton pump Inhibitor-Refractory symptoms. Gastroenterology. 2020;158(5):1250–1261.e2.
  • Spechler SJ, Hunter JG, Jones KM, et al. Randomized trial of medical versus surgical treatment for refractory heartburn. N Engl J Med. 2019;381(16):1513–1523.
  • Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery. Am J Gastroenterol. 2018;113(8):1137–1147.
  • Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: experience of 109 cases. Dig Endosc. 2021;33(3):347–354.
  • Franciosa M, Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality. Am J Gastroenterol. 2013;108(10):1654–1655.
  • Witteman BPL, Conchillo JM, Rinsma NF, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–542.
  • Li X, Zhang XB, Hu HQ, et al. Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease. Chin Med J (Engl). 2017;130(14):1749–1750.
  • Li ZT, Ji F, Han XW, et al. Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study. Surg Endosc. 2021;35(7):4035–4041.
  • Hu H-Q, Li H-K, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease. Medicine (Baltimore). 2018;97(15):e0169.
  • Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30(10):1030–1038.
  • Chan Y, Ching JYL, Cheung CMY, et al. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire. Aliment Pharmacol Ther. 2010;31(3):452–460.
  • Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020;324(24):2536–2547.
  • Wang SM, Katki HA, Graubard BI, et al. Population attributable risks of subtypes of esophageal and gastric cancers in the United States. Am J Gastroenterol. 2021;116(9):1844–1852.
  • Durazzo M, Lupi G, Cicerchia F, et al. Extra-Esophageal presentation of gastroesophageal reflux disease: 2020 update. J Clin Med. 2020; 9(8):2559.
  • Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51(8):751–767.
  • Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2018;16(6):800–808.e7.
  • Jung DH, Huh CW, Lee SK, et al. A systematic review and meta-analysis of randomized control trials: combination treatment with proton pump inhibitor plus prokinetic for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2021;27(2):165–175.
  • Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022;117(1):27–56.
  • Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American gastroenterological association. Gastroenterology. 2017;152(4):706–715.
  • Fass R, Ofman JJ. Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol. 2002;97(8):1901–1909.
  • Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(6):1058–1067.e1.
  • Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the stretta procedure. Gastrointest Endosc. 2007;65(3):367–372.
  • Wong HJ, Su B, Attaar M, et al. Anti-reflux mucosectomy (ARMS) results in improved recovery and similar reflux quality of life outcomes compared to laparoscopic Nissen fundoplication. Surg Endosc. 2021;35(12):7174–7182.
  • Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009;43(2):111–117.
  • Revicki DA, Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104(3):252–258.
  • Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet. Rocz Panstw Zakl Hig. 2021;72(1):21–28.
  • Sanford Z, Jayaraman S, Weltz AS, et al. The role of body mass index in determining clinical and quality of life outcomes after laparoscopic anti-reflux surgery. Surg Endosc. 2020;34(2):646–657.
  • DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg. 1986;204(1):9–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.